Loading people...
Dr. Frank Hensel is a Principal at High-Tech Gründerfonds based in Bonn, Germany, focusing on early-stage venture capital investments in the life sciences sector. Before joining the firm in 2015, he founded and served as Chief Executive Officer of OncoMab GmbH, a biotechnology spin-off from the University of Würzburg, and later worked as Vice President of Research and Development for Patrys Ltd. During his tenure at HTGF, Hensel has guided three portfolio companies through clinical phases and facilitated notable transactions, including the acquisition of Amal Therapeutics by Boehringer Ingelheim for up to €425 million. He holds a doctorate in immunology from the University of Würzburg and studied biophysics at the University of Osnabrück. His current focus centers on leveraging his operational drug development expertise to identify and scale early-stage therapeutics and medical device startups.
Frank Hensel is a distinguished Principal at High-Tech Gründerfonds (HTGF), a pivotal player in the European venture capital landscape. As one of Germany's most active seed investors, HTGF provides crucial early-stage funding to high-potential technology startups, and Frank Hensel is instrumental in driving this mission forward. His expertise lies in identifying groundbreaking innovations and nurturing them from concept to market leader.
At High-Tech Gründerfonds, Frank Hensel's primary role involves sourcing, evaluating, and investing in promising early-stage technology companies. He is deeply involved in the entire investment process, from initial contact and comprehensive due diligence to structuring investment deals and providing ongoing support to portfolio companies. His investment focus spans a broad range of sectors critical to the digital and industrial future, including cutting-edge software solutions, scalable digital business models, and advanced industrial technology. He actively seeks out startups that demonstrate strong technological differentiation, significant market potential, and a passionate, capable founding team.
Frank's career background is rooted in a deep understanding of technology and business development. Prior to his tenure at HTGF, he cultivated extensive experience in various capacities within the tech ecosystem, including roles that provided him with a keen insight into corporate strategy, market analysis, and the operational challenges faced by nascent companies. This diverse background equips him with a unique perspective, enabling him to not only assess the technical viability of a startup but also its commercial potential and strategic fit within the broader market. His hands-on approach and strategic guidance are invaluable to the entrepreneurs he supports, helping them navigate the complexities of growth and fundraising.
Through his work at High-Tech Gründerfonds, Frank Hensel contributes significantly to the development of the next generation of technology leaders. While specific individual investments are part of HTGF's collective portfolio success, his efforts have directly contributed to the growth and successful scaling of numerous innovative ventures. He is known for his commitment to fostering innovation and for building strong, collaborative relationships with founders, offering mentorship and leveraging HTGF's extensive network to provide strategic advantages to portfolio companies. Frank Hensel's dedication ensures that High-Tech Gründerfonds continues to be a vital catalyst for technological advancement and economic growth in Germany and beyond.
Frank Hensel is a Principal at High-Tech Gründerfonds (HTGF), a leading early-stage venture capital firm in Europe. He specializes in investing in innovative technology startups.
Frank Hensel primarily invests in early-stage technology companies. His focus areas include software, digital business models, and industrial technology, seeking out high-potential startups with strong innovation.
Frank Hensel works as a Principal at High-Tech Gründerfonds (HTGF), one of Germany's most active seed investors, based in Bonn, Germany.